Starpharma is covered by research analysts, including:
| Firm | Analyst |
| Nomura | David Stanton / Zara Lyons |
| Bell Potter | Stuart Roberts |
| Shaw Stockbroking | Mathijs Smith |
| Morningstar | James Cooper |
| Bioshares (Sector Analysis) | David Blake / Mark Pachacz |
Please note that any opinions, estimates or forecasts regarding Starpharma's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Starpharma or its management. Starpharma does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Starpharma cannot guarantee its accuracy.
| Nomura Equity Research initiated coverage in November 2011 |
| Access the report from Nomura's website |
| Nomura Update February 1, 2012 - Positive preclinicals for dendrimer-docetaxel |